Trial Profile
Prospective pharmacokinetics and pharmacodynamics study investigating the long term effect of natalizumab treatment in multiple sclerosis patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Dec 2015
Price :
$35
*
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics; Pharmacokinetics
- 23 Dec 2015 New trial record